Genomics Research Science Whitepapers | Page 5

Whitepaper

Making the Switch to In-House Mycoplasma Testing

Many regulatory guidelines state that cell banks and cultures used in the production of biologics must be tested for mycoplasma. Mycoplasma infections can cause severe problems in manufacturing as these organisms can alter DNA, RNA and modify host cell plasma membrane antigens.

Whitepaper

Quantitative and Reproducible Bioconjugation

Bioconjugation is the chemical linking of two biomolecules to form a single hybrid that retains the biological activity of each component, yet provides a novel function that is not possible with each individual biomolecule.

Whitepaper

Insight - Research Advancements with Proteomics Technology

Proteins are one of the most vital parts of living organisms with many functions, using the latest proteomics methods it is now possible to understand how protein changes in our body influence health and disease, particularly during ageing.

Whitepaper

Accelerating Drug Discovery With an Automated Single-Cell Workflow

Single-cell sequencing is quickly becoming a standard tool in biological research due to the scale and depth of insight it provides across diverse cell populations. The pharmaceutical industry is exploiting single-cell approaches to identify novel therapeutic targets and accelerate promising assets through development.

Whitepaper

Solutions for Host Cell Protein Analysis

Download this whitepaper to discover approaches for the detection and quantification of HCPs that streamline the process of impurity monitoring, have broad sample applicability through mass spectrometry and consider patient safety, product stability and purity.

Whitepaper

Traceability in Western Blot Imaging: Considerations for GxP Regulations

Densitometry analysis of gels is a key part of quality control in the drug release process, thus a workflow that considers all steps regarding traceability, accountability and data integrity is paramount.

Whitepaper

Join the mRNA Vaccine Race With Affinity Purification

mRNA based interventions are becoming much more prevalent in current times, with several leading SARS-CoV-2 vaccines relying on mRNA technology. Access this whitepaper to learn about an affinity-based method that can streamline mRNA vaccine production and be used for biotherapeutic development.